Health-related quality of life (HRQoL) has become an increasingly important secondary
outcome in clinical trials in glioma patients. Both the tumour and its treatment may have an …

Glioblastoma (GBM) commonly presents with symptoms including headaches, seizures,
nausea, vomiting, and cognitive decline. The specific symptoms experienced may differ …

Glioma patients carry the burden of having both a progressive neurological disease and
cancer, and may face a variety of symptoms, including depression and anxiety. These …

Introduction Guidelines recommend that brain tumour patients have their unmet needs
assessed by a Holistic Needs Assessment (HNA), followed by appropriate support and care …

Patients diagnosed with primary brain tumors (PBTs) exhibit high psychological distress.
This mixed-methods study assessed how symptoms of anxiety, depression and emotional …

De acuerdo a la Organización Mundial de la Salud, la depresión afecta a más de 300
millones de personas en el mundo; por lo que se le considera un severo problema de salud …

La presente revisión tuvo como objetivo evaluar la eficacia y seguridad de la Duloxetina
para el tratamiento de la depresión moderada a severa en pacientes con cáncer y dolor …